Georgia Medical Cannabis Program Expands Rapidly Despite Federal Regulatory Uncertainty

Georgia's medical cannabis program continues its rapid expansion, yet state regulators are calling for clearer guidance from the U.S. Drug Enforcement Administration to better navigate federal oversight. The lack of DEA direction creates challenges for program implementation and patient access to cannabis-based therapeutic options. This growth reflects increasing state-level support for medical cannabis despite the federal scheduling status that complicates interstate commerce and banking. Georgia's expanding program demonstrates the growing disconnect between state medical cannabis policies and federal drug enforcement priorities, affecting patients seeking alternative therapeutic interventions.